Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04397614 · ClinicalTrials.gov registry record · NA
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT04397614 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 128 participants.
The verdict
NCT04397614, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that are consistent with early signs of SARS-CoV-2 infection in this high-risk population by automatically (and securely) transferring this information to health care providers. The primary aim of this study is to determine the feasibility, ease of use, and perceived utility of this app to monitor symptoms and health risk behaviors among cancer patients currently receiving chemotherapy.
Interventions
- OTHER mHealth Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2021-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04397614
The ClinicalTrials.gov registry entry for NCT04397614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mHealth Assessments is the first listed.
NCT04397614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04397614 about?
NCT04397614 is a clinical study titled "Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients". The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that are consistent with early s...
What is the current status of trial NCT04397614?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2020-07-22. Estimated completion is 2021-11-12.
What interventions are being tested in trial NCT04397614?
The interventions under investigation include: mHealth Assessments (OTHER).
Who is sponsoring clinical trial NCT04397614?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.